Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05696769 · ClinicalTrials.gov registry record

Tourette Discrimination (TD) Stigma Scale

A clinical trial of Tourette Syndrome and Tourette Syndrome in Adolescence, sponsored by Wake Forest University Health Sciences.

Completed
Registry status
43
Enrollment target
1
Study location

NCT05696769 is a study of Tourette Syndrome and Tourette Syndrome in Adolescence that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 43 participants, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05696769, a study of Tourette Syndrome and Tourette Syndrome in Adolescence, has completed, sponsored by Wake Forest University Health Sciences.

COMPLETED
Registry status
43 participants
Enrollment target
1
Study location

Study Summary

The goal of this qualitative study is to understand the challenges of stigmatization and discrimination in children and young adults with Chronic Tic Disorders (CTD), including Tourette Syndrome. Measuring and understanding how stigma affects those with CTD will help inform future work.

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2023-03-04
Est. Completion 2024-06-27

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT05696769

The ClinicalTrials.gov registry entry for NCT05696769 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 85-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (49% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 0 interventions.

NCT05696769 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT05696769 about?

NCT05696769 is a clinical study titled "Tourette Discrimination (TD) Stigma Scale". The goal of this qualitative study is to understand the challenges of stigmatization and discrimination in children and young adults with Chronic Tic Disorders (CTD), including Tourette Syndrome. Measuring and understanding how stigma affects those with CTD will help inform future work.

What is the current status of trial NCT05696769?

This trial is currently completed. The enrollment target is 43 participants. The study started on 2023-03-04. Estimated completion is 2024-06-27.

What conditions does trial NCT05696769 study?

This clinical trial studies the following conditions: Tourette Syndrome, Tourette Syndrome in Adolescence, Tics, Tourette Syndrome in Children, Tic Disorder, Childhood.

Who is sponsoring clinical trial NCT05696769?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05696769 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.